Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

References

• HøvdingGAcute bacterial conjunctivitisActa Ophthalmol2008861517
   Web of Science ®Google Scholar
• DiamantJIHwangDGTherapy for bacterial conjunctivitisOphthalmol Clin North Am19991211520
   Google Scholar
• SheikhAHurwitzBAntibiotics versus placebo for acute bacterial conjunctivitisCochrane Database Syst Rev20062CD00121116625540
   PubMed Web of Science ®Google Scholar
• MuellerJBMcStayCMOcular infection and inflammationEmerg Med Clin North Am2008261577218249257
   PubMed Web of Science ®Google Scholar
• CavuotoKZutshiDKarpCLMillerDFeuerWUpdate on bacterial conjunctivitis in South FloridaOphthalmology20081151515617572497
   PubMed Web of Science ®Google Scholar
• WardKWLepageJ-FDriotJ-YNonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic useJ Ocul Pharmacol Ther200723324325617593008
   PubMed Web of Science ®Google Scholar
• HaasWPillarCMZurenkoGELeeJCBrunnerLSMorrisTWBesifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteriaAntimicrob Agents Chemother20095383552356019506065
   PubMed Web of Science ®Google Scholar
• HaasWPillarCMHesjeCKSanfillippoCMMorrisTWIn vitro time-kill experiments with besifloxacin and gatifloxacin in the absence and presence of benzalkonium chlorideJ Antimicrob Chemother201166484084421393192
   PubMed Web of Science ®Google Scholar
• ProkschJWGranvilCPSiou-MermetRComstockTLPaternoMRWardKWOcular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humansJ Ocul Pharmacol Ther200925433534319492955
   PubMed Web of Science ®Google Scholar
• TorkildsenGProkschJWShapiroALynchSKComstockTLConcentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administrationClin Ophthalmol2010433134120463802
   PubMedGoogle Scholar
• CarterNJScottLJBesifloxacin ophthalmic suspension 0.6%Drugs2010701839720030427
   PubMed Web of Science ®Google Scholar
• ComstockTLKarpeckiPMMorrisTWZhangJZBesifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitisClin Ophthalmol2010421522520463787
   PubMedGoogle Scholar
• ChangMHFungHBBesifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitisClin Ther201032345447120399984
   PubMed Web of Science ®Google Scholar
• SilversteinBEAllaireCBatemanKMGearingerLSMorrisTWComstockTLEfficacy and tolerability of besifloxacin 0.6% ophthalmic suspension administered twice daily for three days in the treatment of bacterial conjunctivitis: a multicenter, double-masked, vehicle controlled, parallel-group study in adults and childrenClin Ther2011331132621397770
   PubMed Web of Science ®Google Scholar
• KarpeckiPDepaolisMHunterJABesifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: a multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety studyClin Ther200931351452619393842
   PubMed Web of Science ®Google Scholar
• TepedinoMEHellerWHUsnerDWPhase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitisCurr Med Res Opin20092551159116919323612
   PubMed Web of Science ®Google Scholar
• McDonaldMBProtzkoEEBrunnerLSEfficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution, 0.5%, for treating bacterial conjunctivitisOphthalmology200911691615162319643483
   PubMed Web of Science ®Google Scholar
• CagleGDavisSRosenthalASmithJTopical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter studyCurr Eye Res1981195235347341065
   PubMed Web of Science ®Google Scholar
• HassWGearingerLSUsnerDWDeCoryHHMorrisTWIntegrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profileClin Ophthalmol2011In press
   Google Scholar
• LeibowitzHMAntibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitisAm J Ophthalmol1991112 Suppl 429S33S1928271
   PubMedGoogle Scholar
• Clinical and Laboratory Standards InstituteMethods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standardsixth editionCLSI document M07-A6Wayne, PAClinical and Laboratory Standards Institute2003
   Google Scholar
• Clinical and Laboratory Standards InstituteMethods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standardseventh editionCLSI document M07-A7Wayne, PAClinical and Laboratory Standards Institute2006
   Google Scholar
• Clinical and Laboratory Standards InstitutePerformance standards for antimicrobial susceptibility testing; fourteenth informational supplementCLSI document: M100-S14Wayne, PAClinical and Laboratory Standards Institute2004
   Google Scholar
• Clinical and Laboratory Standards InstitutePerformance standards for antimicrobial susceptibility testing; sixteenth informational supplementCLSI document M100-S16Wayne, PAClinical and Laboratory Standards Institute2006
   Google Scholar
• IchiyamaSOhtaMShimokataKKatoNTakeuchiJGenomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureusJ Clin Microbiol19912912269026951757534
   PubMed Web of Science ®Google Scholar
• TenoverFCArbeitRDGoeringRVInterpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typingJ Clin Microbiol1995339223322397494007
   PubMed Web of Science ®Google Scholar
• TarabishyABJengBHBacterial conjunctivitis: a review for internistsCleve Clin J Med200875750751218646586
   PubMed Web of Science ®Google Scholar
• GigliottiFWilliamsWTHaydenFGEtiology of acute conjunctivitis in childrenJ Pediatr19819845315366970802
   PubMed Web of Science ®Google Scholar
• BrookIPettitTHMartinWJFinegoldSMAnaerobic and aerobic bacteriology of acute conjunctivitisAnn Ophthalmol1979113389393313179
   PubMedGoogle Scholar
• McDonnellGRussellADAntiseptics and disinfectants: activity, action and resistanceClin Microb Rev1999121147179
   PubMed Web of Science ®Google Scholar
• BlondeauJMBorosSHesjeCKAntimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureusJ Chemother200719214615117434822
   PubMed Web of Science ®Google Scholar